Company: MDCXW
Filing Date: 2025-05-27
Form Type: S-1
Source: 0001062993-25-010333
Chunk: 198

Company: Medicus Pharma Ltd.
Filing Date: 2025-05-27
Form: S-1
Chunk 198
---
 party, and no provision of the SEPA may be modified or waived by the parties other than by an instrument in writing signed by both parties.

The net proceeds from sales, if any, under the SEPA, will depend on the frequency and prices at which we sell common shares to the Selling Shareholder.

As consideration for the Selling Shareholder's commitment to purchase our common shares at our direction upon the terms and subject to the conditions set forth in the SEPA, upon execution of the SEPA, we issued 105,840 Commitment Shares to the Selling Shareholder as set forth in the SEPA.

The SEPA contains customary representations, warranties, conditions, and indemnification obligations of the parties. The representations, warranties, and covenants contained in such agreements were made only for purposes of such agreements and as of specific dates, were solely for the benefit of the parties to such agreements and may be subject to limitations agreed upon by the contracting parties.

<div align='center'>- 132 -</div>

Advances of Common Shares Under the SEPA

We will have the right, but not the obligation, from time to time, at our sole and exclusive discretion, for the 36-month period after the date of the SEPA, to direct the Selling Shareholder to purchase up to a specified maximum amount of common shares as set forth in the SEPA by delivering written notice to the Selling Shareholder (each, an "Advance Notice") on any trading day (each, an "Advance Notice Date").

Conditions to Each Advance

The Selling Shareholder's obligation to accept Advance Notices that are timely delivered by us under the SEPA and to purchase our common shares in Advances under the SEPA are subject to the satisfaction, at the applicable Advance Notice Date, of the conditions precedent thereto set forth in the SEPA, all of which are entirely outside of the Selling Shareholder's control, which conditions include the following: (i) the accuracy in all material respects of our representations and warranties included in the SEPA; (ii) there being an effective registration statement pursuant to which the Selling Shareholder is permitted to utilize the prospectus thereunder to resell all of the Advance Shares pursuant to such Advance Notice; (iii) the sale and issuance of such Advance Shares being legally permitted by all laws and regulations to which we are subject; (iv) no Material Outside Event (as such term is defined in the SEPA) shall have occurred and be continuing; (v) the approval of our board of directors with respect to the